Morpholine → HCID 11717388, compound
Reaction equation
Cl.Cl.[CH2:3]([N:5]1[CH2:10][CH2:9][CH:8]([NH:11][C:12]2[CH:13]=[C:14]3[C:18](=[CH:19][CH:20]=2)[NH:17][C:16]([C:21](O)=[O:22])=[CH:15]3)[CH2:7][CH2:6]1)[CH3:4].F[B-](F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2C=CC=CC=2N=N1.CCN(C(C)C)C(C)C.[NH:55]1[CH2:60][CH2:59][O:58][CH2:57][CH2:56]1>CN(C=O)C>[CH2:3]([N:5]1[CH2:6][CH2:7][CH:8]([NH:11][C:12]2[CH:13]=[C:14]3[C:18](=[CH:19][CH:20]=2)[NH:17][C:16]([C:21]([N:55]2[CH2:60][CH2:59][O:58][CH2:57][CH2:56]2)=[O:22])=[CH:15]3)[CH2:9][CH2:10]1)[CH3:4]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of 0.15 g 5-(1-ethyl-piperidin-4-ylamino)-1H-indole-2-carboxylic acid (intermediate 3), 0.16 g O-benzotriazol-1-yl-N,N,N′,N′-tetramethyluronium tetrafluoroborate (TBTU), 0.323 g DIPEA and 0.044 g morpholine in 2 ml DMF was reacted for 1 h at room temperature and evaporated to dryness. The residue was treated with ethyl acetate, water and NaHCO3 aq. The aqueous phases were further extracted with ethyl acetate and the combined organic phases were dried over Na2SO4, filtered and evaporated. The residue was further purified by chromatography and crystallization to yield 0.09 g (60%) of the title compound as light brown solid. MS (m/e): 357.4 (MH+, 100%).
Workup
- customwas reacted for 1 h at room temperature
- customevaporated to dryness
- additionThe residue was treated with ethyl acetate, water and NaHCO3 aq. The aqueous phases
- extractionwere further extracted with ethyl acetate
- dry with materialthe combined organic phases were dried over Na2SO4
- filtrationfiltered
- customevaporated
- customThe residue was further purified by chromatography and crystallization
Sources & evidence
- ORD record
- ord-9bbd038283fd403da7f01624b1e93737
- Source dataset
- uspto-grants-2010_07
- Patent number
- US07754736B2
Reaction notes
Loading…